{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:37:10Z","timestamp":1758476230695},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T00:00:00Z","timestamp":1160524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1741-7015-4-25","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T18:28:47Z","timestamp":1160591327000},"source":"Crossref","is-referenced-by-count":4,"title":["Acute ischemic heart disease and interventional cardiology: a time for pause"],"prefix":"10.1186","volume":"4","author":[{"given":"Peter","family":"Bogaty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,10,11]]},"reference":[{"key":"88_CR1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1056\/NEJMe038116","volume":"349","author":"AK Jacobs","year":"2003","unstructured":"Jacobs AK: Primary angioplasty for acute myocardial infarction\u2013is it worth the wait?. N Engl J Med. 2003, 349: 798-800.","journal-title":"N Engl J Med"},{"key":"88_CR2","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1161\/01.CIR.0000075292.29458.BB","volume":"107","author":"CL Grines","year":"2003","unstructured":"Grines CL, Serruys P, O'Neill WW: Fibrinolytic therapy: is it a treatment of the past?. Circulation. 2003, 107: 2538-2542.","journal-title":"Circulation"},{"key":"88_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.CIR.0000082932.69023.74","volume":"108","author":"CM Gibson","year":"2003","unstructured":"Gibson CM: Has my patient achieved adequate myocardial reperfusion?. Circulation. 2003, 108: 504-507.","journal-title":"Circulation"},{"key":"88_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0140-6736(02)11010-5","volume":"360","author":"GW Stone","year":"2002","unstructured":"Stone GW: Primary angioplasty versus \"earlier\" thrombolysis\u2013time for a wake-up call. Lancet. 2002, 360: 814-816.","journal-title":"Lancet"},{"key":"88_CR5","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.jacc.2003.12.057","volume":"43","author":"RE Waters 2nd","year":"2004","unstructured":"Waters RE, Singh KP, Roe MT, Lotfi M, Sketch MH, Mahaffey KW, Newby LK, Alexander JH, Harrington RA, Califf RM, Granger CB: Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004, 43: 2153-2159.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"EC Keeley","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003, 361: 13-20.","journal-title":"Lancet"},{"key":"88_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7326\/0003-4819-141-4-200408170-00009","volume":"141","author":"JM Brophy","year":"2004","unstructured":"Brophy JM, Bogaty P: Primary angioplasty and thrombolysis are both reasonable options in acute myocardial infarction. Ann Intern Med. 2004, 141: 292-297.","journal-title":"Ann Intern Med"},{"key":"88_CR8","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1001\/jama.283.20.2686","volume":"283","author":"LJ Morrison","year":"2000","unstructured":"Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ: Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA. 2000, 283: 2686-2692.","journal-title":"JAMA"},{"key":"88_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","volume":"109","author":"G De Luca","year":"2004","unstructured":"De Luca G, Suryapranata H, Ottervanger JP, Antman EM: Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004, 109: 1223-1225.","journal-title":"Circulation"},{"key":"88_CR10","doi-asserted-by":"crossref","unstructured":"Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994, 343: 311-322.","DOI":"10.1016\/S0140-6736(94)91161-4"},{"key":"88_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","volume":"348","author":"E Boersma","year":"1996","unstructured":"Boersma E, Maas AC, Deckers JW, Simoons ML: Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996, 348: 771-775.","journal-title":"Lancet"},{"key":"88_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0002-9149(03)00891-9","volume":"92","author":"BK Nallamothu","year":"2003","unstructured":"Nallamothu BK, Bates ER: Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol. 2003, 92: 824-826.","journal-title":"Am J Cardiol"},{"key":"88_CR13","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.jacc.2005.12.072","volume":"47","author":"RL McNamara","year":"2006","unstructured":"McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, Peterson ED, Blaney M, Frederick PD, Krumholz HM: Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006, 47: 2180-2186.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(02)09963-4","volume":"360","author":"E Bonnefoy","year":"2002","unstructured":"Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, Cattan S, Boullenger E, Machecourt J, Lacroute JM, Cassagnes J, Dissait F, Touboul P: Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002, 360: 825-829.","journal-title":"Lancet"},{"key":"88_CR15","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1161\/01.CIR.0000103122.10021.F2","volume":"108","author":"PG Steg","year":"2003","unstructured":"Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P: Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003, 108: 2851-2856.","journal-title":"Circulation"},{"key":"88_CR16","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJM200005253422106","volume":"342","author":"JG Canto","year":"2000","unstructured":"Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, French WJ, Tiefenbrunn AJ, Misra VK, Kiefe CI, Barron HV, for the National Registry of Myocardial Infarction 2 Investigators: The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med. 2000, 342: 1573-1580.","journal-title":"N Engl J Med"},{"key":"88_CR17","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0735-1097(98)00094-1","volume":"31","author":"AJ Tiefenbrunn","year":"1998","unstructured":"Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ: Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 1998, 31: 1240-1245.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/01.CIR.0000155258.44268.F8","volume":"111","author":"BK Nallamothu","year":"2005","unstructured":"Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM: Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3\/4 analysis. Circulation. 2005, 111: 761-767.","journal-title":"Circulation"},{"key":"88_CR19","doi-asserted-by":"crossref","unstructured":"Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001, 358: 605-613.","DOI":"10.1016\/S0140-6736(01)05775-0"},{"key":"88_CR20","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(00)05059-5","volume":"357","author":"EJ Topol","year":"2001","unstructured":"Topol EJ: Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb\/IIIa inhibition: the GUSTO V randomised trial. Lancet. 2001, 357: 1905-1914.","journal-title":"Lancet"},{"key":"88_CR21","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1001\/jama.284.24.3131","volume":"284","author":"DJ Magid","year":"2000","unstructured":"Magid DJ, Calonge BN, Rumsfeld JS, Canto JG, Frederick PD, Every NR, Barron HV: Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000, 284: 3131-3138.","journal-title":"JAMA"},{"key":"88_CR22","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0735-1097(03)00461-3","volume":"41","author":"JP Henriques","year":"2003","unstructured":"Henriques JP, Haasdijk AP, Zijlstra F: Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours. J Am Coll Cardiol. 2003, 41: 2138-2142.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR23","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1161\/01.CIR.0000134791.68010.FA","volume":"110","author":"EM Antman","year":"2004","unstructured":"Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004, 110: e82-292.","journal-title":"Circulation"},{"key":"88_CR24","doi-asserted-by":"crossref","unstructured":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993, 329: 673-682.","DOI":"10.1056\/NEJM199309023291001"},{"key":"88_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","volume":"114","author":"JW Eikelboom","year":"2006","unstructured":"Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S: Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006, 114: 774-782.","journal-title":"Circulation"},{"key":"88_CR26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa050522","volume":"352","author":"MS Sabatine","year":"2005","unstructured":"Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005, 352: 1179-1189.","journal-title":"N Engl J Med"},{"key":"88_CR27","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","volume":"366","author":"ZM Chen","year":"2005","unstructured":"Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS: Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005, 366: 1622-1632.","journal-title":"Lancet"},{"key":"88_CR28","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1161\/01.CIR.0000102947.33318.E8","volume":"108","author":"G Melandri","year":"2003","unstructured":"Melandri G: The obsession with primary angioplasty. Circulation. 2003, 108: e162.","journal-title":"Circulation"},{"key":"88_CR29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.amjcard.2005.07.058","volume":"96","author":"G Tarantini","year":"2005","unstructured":"Tarantini G, Razzolini R, Ramondo A, Napodano M, Bilato C, Iliceto S: Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction. Am J Cardiol. 2005, 96: 1503-1505.","journal-title":"Am J Cardiol"},{"key":"88_CR30","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1161\/CIRCULATIONAHA.105.558676","volume":"112","author":"JJ Thune","year":"2005","unstructured":"Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen HR, Nielsen TT, Kober L, Kelbaek H: Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation. 2005, 112: 2017-2021.","journal-title":"Circulation"},{"key":"88_CR31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.1525-1497.2002.11232.x","volume":"17","author":"DM Kent","year":"2002","unstructured":"Kent DM, Schmid CH, Lau J, Selker HP: Is primary angioplasty for some as good as primary angioplasty for all?. J Gen Intern Med. 2002, 17: 887-894.","journal-title":"J Gen Intern Med"},{"key":"88_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jacc.2004.03.058","volume":"44","author":"CO Costantini","year":"2004","unstructured":"Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, Stuckey T, Turco M, Gersh BJ, Tcheng JE, Garcia E, Griffin JJ, Guagliumi G, Leon MB, Lansky AJ: Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb\/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol. 2004, 44: 305-312.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jacc.2003.12.059","volume":"44","author":"AG Sutton","year":"2004","unstructured":"Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder M: A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol. 2004, 44: 287-296.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/hrt.2004.047753","volume":"91","author":"AG Sutton","year":"2005","unstructured":"Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA: One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial. Heart. 2005, 91: 1330-1337.","journal-title":"Heart"},{"key":"88_CR35","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1056\/NEJMoa050849","volume":"353","author":"AH Gershlick","year":"2005","unstructured":"Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, de Belder A, Davis J, Pitt M, Banning A, Baumbach A, Shiu MF, Schofield P, Dawkins KD, Henderson RA, Oldroyd KG, Wilcox R: Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005, 353: 2758-2768.","journal-title":"N Engl J Med"},{"key":"88_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/01.CIR.88.2.416","volume":"88","author":"A Volpi","year":"1993","unstructured":"Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G: Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation. 1993, 88: 416-429.","journal-title":"Circulation"},{"key":"88_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/0735-1097(94)90004-3","volume":"24","author":"A Volpi","year":"1994","unstructured":"Volpi A, de Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Sontoro E, Tavazzi L, Tognoni G: Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base. J Am Coll Cardiol. 1994, 24: 608-615.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR38","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.CIR.96.3.748","volume":"96","author":"JK Madsen","year":"1997","unstructured":"Madsen JK, Grande P, Saunamaki K, Thayssen P, Kassis E, Eriksen U, Rasmussen K, Haunso S, Nielsen TT, Haghfelt T, Fritz-Hansen P, Hjelms E, Paulsen PK, Alstrup P, Arendrup H, Niebuhr-Jorgensen U, Andersen LI: Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation. 1997, 96: 748-755.","journal-title":"Circulation"},{"key":"88_CR39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/01.CIR.99.9.1272","volume":"99","author":"P Bogaty","year":"1999","unstructured":"Bogaty P, Dagenais GR, Madsen JK, Grande P: Revascularization after myocardial infarction. Circulation. 1999, 99: 1272-1273.","journal-title":"Circulation"},{"key":"88_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.CIR.0000153621.57449.8E","volume":"111","author":"GW Vetrovec","year":"2005","unstructured":"Vetrovec GW: Optimizing percutaneous coronary intervention outcomes: the next steps. Circulation. 2005, 111: 125-126.","journal-title":"Circulation"},{"key":"88_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/pcad.2002.123464","volume":"45","author":"JS Forrester Jr","year":"2002","unstructured":"Forrester JS, Liebson PR, Parrillo JE, Klein LW: Risk stratification post-myocardial infarction: is early coronary angiography the more effective strategy?. Prog Cardiovasc Dis. 2002, 45: 49-66.","journal-title":"Prog Cardiovasc Dis"},{"key":"88_CR42","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0140-6736(04)17059-1","volume":"364","author":"F Fernandez-Aviles","year":"2004","unstructured":"Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, Vazquez N, Blanco J, Alonso-Briales J, Lopez-Mesa J, Fernandez-Vazquez F, Calvo I, Martinez-Elbal L, San Roman JA, Ramos B: Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004, 364: 1045-1053.","journal-title":"Lancet"},{"key":"88_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0140-6736(05)70223-3","volume":"365","author":"P Bogaty","year":"2005","unstructured":"Bogaty P, Brophy J: Implications for clinical practice. Lancet. 2005, 365: 381.","journal-title":"Lancet"},{"key":"88_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/01.CIR.79.2.441","volume":"79","author":"E Braunwald","year":"1989","unstructured":"Braunwald E: Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?. Circulation. 1989, 79: 441-444.","journal-title":"Circulation"},{"key":"88_CR45","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0735-1097(02)02058-2","volume":"40","author":"ZR Yousef","year":"2002","unstructured":"Yousef ZR, Redwood SR, Bucknall CA, Sulke AN, Marber MS: Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol. 2002, 40: 869-876.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR46","unstructured":"ClinicalTrials.gov. [ http:\/\/www.clinicaltrials.gov\/ct ]"},{"key":"88_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0735-1097(03)00507-2","volume":"42","author":"WW O'Neill","year":"2003","unstructured":"O'Neill WW: \"Watchful waiting\" after thrombolysis: it's time for a re-evaluation. J Am Coll Cardiol. 2003, 42: 17-19.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR48","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurheartj\/ehi564","volume":"26","author":"S Silber","year":"2005","unstructured":"Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W: Guidelines for percutaneous coronary interventions: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J. 2005, 26: 804-847.","journal-title":"Eur Heart J"},{"key":"88_CR49","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","volume":"344","author":"CP Cannon","year":"2001","unstructured":"Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban. N Engl J Med. 2001, 344: 1879-1887.","journal-title":"N Engl J Med"},{"key":"88_CR50","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","volume":"354","author":"FRagmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) Investigators","year":"1999","unstructured":"FRagmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) Investigators: Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999, 354: 708-715.","journal-title":"Lancet"},{"key":"88_CR51","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/0735-1097(95)00404-1","volume":"26","author":"HV Anderson","year":"1995","unstructured":"Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E: One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995, 26: 1643-1650.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR52","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","volume":"338","author":"WE Boden","year":"1998","unstructured":"Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW, for the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators: Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 1998, 338: 1785-1792.","journal-title":"N Engl J Med"},{"key":"88_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","volume":"356","author":"L Wallentin","year":"2000","unstructured":"Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 2000, 356: 9-16.","journal-title":"Lancet"},{"key":"88_CR54","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/S0735-1097(02)01841-7","volume":"39","author":"A Goyal","year":"2002","unstructured":"Goyal A, Samaha FF, Boden WE, Wade MJ, Kimmel SE: Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trial. J Am Coll Cardiol. 2002, 39: 1601-1607.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR55","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","volume":"100","author":"EM Antman","year":"1999","unstructured":"Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E: Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation. 1999, 100: 1593-1601.","journal-title":"Circulation"},{"key":"88_CR56","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","volume":"360","author":"KA Fox","year":"2002","unstructured":"Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ: Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet. 2002, 360: 743-751.","journal-title":"Lancet"},{"key":"88_CR57","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1161\/01.CIR.0000037106.76139.53","volume":"106","author":"E Braunwald","year":"2002","unstructured":"Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC: ACC\/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction\u20132002: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002, 106: 1893-1900.","journal-title":"Circulation"},{"key":"88_CR58","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0735-1097(01)01388-2","volume":"38","author":"PA Heidenreich","year":"2001","unstructured":"Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA: The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001, 38: 478-485.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR59","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1001\/jama.293.23.2908","volume":"293","author":"SR Mehta","year":"2005","unstructured":"Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S: Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005, 293: 2908-2917.","journal-title":"JAMA"},{"key":"88_CR60","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(05)67222-4","volume":"366","author":"KA Fox","year":"2005","unstructured":"Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TR, Wheatley DJ, Knight R, Pocock SJ: 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet. 2005, 366: 914-920.","journal-title":"Lancet"},{"key":"88_CR61","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa044259","volume":"353","author":"RJ de Winter","year":"2005","unstructured":"de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt FW: Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005, 353: 1095-1104.","journal-title":"N Engl J Med"},{"key":"88_CR62","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","volume":"344","author":"G Montalescot","year":"2001","unstructured":"Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansieri M, Choussat R, Pinton P: Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001, 344: 1895-1903.","journal-title":"N Engl J Med"},{"key":"88_CR63","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/01.CIR.0000103121.26241.FA","volume":"108","author":"A Bakhai","year":"2003","unstructured":"Bakhai A, Stone GW, Grines CL, Murphy SA, Githiora L, Berezin RH, Cox DA, Stuckey T, Griffin JJ, Tcheng JE, Cohen DJ: Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. Circulation. 2003, 108: 2857-2863.","journal-title":"Circulation"},{"key":"88_CR64","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1001\/jama.293.17.2109","volume":"293","author":"M Valgimigli","year":"2005","unstructured":"Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, Cicchitelli G, McFadden EP, Merlini F, Ansani L, Guardigli G, Bettini A, Parrinello G, Boersma E, Ferrari R: Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA. 2005, 293: 2109-2117.","journal-title":"JAMA"},{"key":"88_CR65","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.293.11.1383","volume":"293","author":"SS Rathore","year":"2005","unstructured":"Rathore SS, Epstein AJ, Volpp KG, Krumholz HM: Regionalization of care for acute coronary syndromes: more evidence is needed. JAMA. 2005, 293: 1383-1387.","journal-title":"JAMA"},{"key":"88_CR66","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0002-9149(99)80238-0","volume":"76","author":"MJ de Boer","year":"1995","unstructured":"de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JC, Zijlstra F: A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol. 1995, 76: 830-833.","journal-title":"Am J Cardiol"},{"key":"88_CR67","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0735-1097(97)00041-7","volume":"29","author":"GW Stone","year":"1997","unstructured":"Stone GW, Grines CL, Rothbaum D, Browne KF, O'Keefe J, Overlie PA, Donohue BC, Chelliah N, Vlietstra R, Catlin T, O'Neill WW, for the PAMI Trial Investigators: Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol. 1997, 29: 901-907.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR68","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1161\/01.CIR.0000097120.26062.FE","volume":"108","author":"MR Le May","year":"2003","unstructured":"Le May MR, Davies RF, Labinaz M, Sherrard H, Marquis JF, Laramee LA, O'Brien ER, Williams WL, Beanlands RS, Nichol G, Higginson LA: Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study. Circulation. 2003, 108: 2624-2630.","journal-title":"Circulation"},{"key":"88_CR69","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1001\/jama.288.15.1851","volume":"288","author":"EM Mahoney","year":"2002","unstructured":"Mahoney EM, Jurkovitz CT, Chu H, Becker ER, Culler S, Kosinski AS, Robertson DH, Alexander C, Nag S, Cook JR, Demopoulos LA, DiBattiste PM, Cannon CP, Weintraub WS: Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA. 2002, 288: 1851-1858.","journal-title":"JAMA"},{"key":"88_CR70","unstructured":"Wennberg JE, (Ed): Practice Variations and the Quality of Surgical Care for Common Conditions: Invasive Treatment of Coronary Artery Disease in The Dartmouth Atlas of Health Care in the United States. Chicago, IL: American Hospital Association. 1999, 152-162."},{"key":"88_CR71","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJM199303183281108","volume":"328","author":"JL Rouleau","year":"1993","unstructured":"Rouleau JL, Moye LA, Pfeffer MA, Arnold JM, Bernstein V, Cuddy TE, Dagenais GR, Geltman EM, Goldman S, Gordon D, for the SAVE Investigators, et al: A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 1993, 328: 779-784.","journal-title":"N Engl J Med"},{"key":"88_CR72","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJM199508313330908","volume":"333","author":"E Guadagnoli","year":"1995","unstructured":"Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD: Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 1995, 333: 573-578.","journal-title":"N Engl J Med"},{"key":"88_CR73","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1056\/NEJM199508313330907","volume":"333","author":"L Pilote","year":"1995","unstructured":"Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ, for the GUSTO-1 Investigators: Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 1995, 333: 565-572.","journal-title":"N Engl J Med"},{"key":"88_CR74","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1161\/01.CIR.102.12.1375","volume":"102","author":"Y Fu","year":"2000","unstructured":"Fu Y, Chang WC, Mark D, Califf RM, Mackenzie B, Granger CB, Topol EJ, Hlatky M, Armstrong PW, for the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators: Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Circulation. 2000, 102: 1375-1381.","journal-title":"Circulation"},{"key":"88_CR75","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5694\/j.1326-5377.2001.tb143185.x","volume":"174","author":"IA Scott","year":"2001","unstructured":"Scott IA, Harden H, Coory M: What are appropriate rates of invasive procedures following acute myocardial infarction? A systematic review. Med J Aust. 2001, 174: 130-136.","journal-title":"Med J Aust"},{"issue":"Suppl 4","key":"88_CR76","first-page":"613","volume":"108","author":"PW Armstrong","year":"2003","unstructured":"Armstrong PW, Chang W-C, Kaul P, Ardissino D, Aylward P, B\u00e4r FW, Betriu A, Bode C, Guetta V, Steg G, Van de Werf F, Lincoff M: What is an optimal rate of early revascularization after ST-elevation myocardial infarction? Insights from the GUSTO-V Trial. Circulation. 2003, 108 (Suppl 4): 613.","journal-title":"Circulation"},{"key":"88_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/bmj.38335.390718.82","volume":"330","author":"F Van de Werf","year":"2005","unstructured":"Van de Werf F, Gore JM, Avezum A, Gulba DC, Goodman SG, Budaj A, Brieger D, White K, Fox KA, Eagle KA, Kennelly BM: Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ. 2005, 330: 441.","journal-title":"BMJ"},{"key":"88_CR78","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jama.293.11.1329","volume":"293","author":"TA Stukel","year":"2005","unstructured":"Stukel TA, Lucas FL, Wennberg DE: Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction. JAMA. 2005, 293: 1329-1337.","journal-title":"JAMA"},{"key":"88_CR79","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0735-1097(01)01131-7","volume":"37","author":"P Bogaty","year":"2001","unstructured":"Bogaty P, Dumont S, O'Hara GE, Boyer L, Auclair L, Jobin J, Boudreault JR: Randomized trial of a noninvasive strategy to reduce hospital stay for patients with low-risk myocardial infarction. J Am Coll Cardiol. 2001, 37: 1289-1296.","journal-title":"J Am Coll Cardiol"},{"key":"88_CR80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJMoa012295","volume":"347","author":"A Buffon","year":"2002","unstructured":"Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A: Widespread coronary inflammation in unstable angina. N Engl J Med. 2002, 347: 5-12.","journal-title":"N Engl J Med"},{"key":"88_CR81","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","volume":"106","author":"G Rioufol","year":"2002","unstructured":"Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A: Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002, 106: 804-808.","journal-title":"Circulation"},{"key":"88_CR82","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/eurheartj\/9.suppl_A.151","volume":"9","author":"D Hackett","year":"1988","unstructured":"Hackett D, Davies G, Maseri A: Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J. 1988, 9: 1317-1323.","journal-title":"Eur Heart J"},{"key":"88_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0735-1097(88)90356-7","volume":"12","author":"JA Ambrose","year":"1988","unstructured":"Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988, 12: 56-62.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"88_CR84","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/01.CIR.78.5.1157","volume":"78","author":"WC Little","year":"1988","unstructured":"Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation. 1988, 78 (1): 1157-1166.","journal-title":"Circulation"},{"key":"88_CR85","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.CIR.87.6.1938","volume":"87","author":"P Bogaty","year":"1993","unstructured":"Bogaty P, Brecker SJ, White SE, Stevenson RN, el-Tamimi H, Balcon R, Maseri A: Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation. 1993, 87: 1938-1946.","journal-title":"Circulation"},{"key":"88_CR86","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/clc.4960210703","volume":"21","author":"A Maseri","year":"1998","unstructured":"Maseri A: Evidence-based medicine: progress but not a final solution. Clin Cardiol. 1998, 21: 463-464.","journal-title":"Clin Cardiol"},{"key":"88_CR87","first-page":"f29","volume":"113","author":"A Maseri","year":"2006","unstructured":"Maseri A: Viewpoint. Circulation. 2006, 113: f29-30.","journal-title":"Circulation"},{"key":"88_CR88","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/CIRCULATIONAHA.105.560466","volume":"113","author":"DA Alter","year":"2006","unstructured":"Alter DA, Stukel TA, Newman A: Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare. Circulation. 2006, 113: 380-387.","journal-title":"Circulation"},{"key":"88_CR89","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1056\/NEJMoa040316","volume":"352","author":"EL Hannan","year":"2005","unstructured":"Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, Culliford AT, Isom OW, Gold JP, Rose EA: Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005, 352: 2174-2183.","journal-title":"N Engl J Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-4-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-4-25\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-4-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T14:49:54Z","timestamp":1587221394000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-4-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,11]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-4-25","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,11]]},"article-number":"25"}}